Get started
Live feed
·
SECFilingvia Quantisnow
Eledon Pharmaceuticals Inc. logo

ELDN: SEC Form S-8 filed by Eledon Pharmaceuticals Inc.

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for ELDN

Across the 20 sessions after earlier ELDN headlines, the stock closed higher 8 times and lower 10 times, with a median move of 3.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

ELDN close-to-close change in the session after earlier headlines
SessionEarlier headlineELDNSPY
Sep 3, 2026Eledon Pharmaceuticals Announces Islet Cell Transplantation IND Submission, First Patients Enrolled in Multiple Transplant Programs, and Reaffirms Plan to Initiate Phase 3 Kidney Transplantation Trial in Fourth Quarter 2026-2.0%+1.0%
Aug 14, 2026Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights-4.3%-0.2%
Jun 22, 2026Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus-2.8%-0.3%
Jun 8, 2026Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine+5.0%+0.2%
Jun 5, 2026Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions-5.3%-2.6%
May 21, 2026Eledon Pharmaceuticals to Present New Long-Term Data from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at American Transplant Congress+1.3%+0.2%
Quantisnow market dataNASDAQ
Eledon Pharmaceuticals Inc. logo
ELDN
Eledon Pharmaceuticals Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2014
Get push alerts for ELDN

Follow ELDN and get a push notification the moment its next story breaks.

Full ELDN profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELDN (Eledon Pharmaceuticals Inc.) and more on Quantisnow.